These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 6943746)

  • 41. [Dynamics of the humoral immunity factors in patients with suppurative-inflammatory processes of the maxillofacial area].
    Zakharov IuS; Ruzin GP
    Stomatologiia (Mosk); 1984; 63(4):31-2. PubMed ID: 6591532
    [No Abstract]   [Full Text] [Related]  

  • 42. [Diagnosis of phlegmons and abscesses of the maxillofacial area by the combined use of the methods of thermography and of determining tissue oxygen tension and oxidative-reductive potential].
    Liuliakin AI
    Stomatologiia (Mosk); 1984; 63(4):26-8. PubMed ID: 6591531
    [No Abstract]   [Full Text] [Related]  

  • 43. [Vacuum drainage and local oxygen therapy in treating patients with abscesses and phlegmons of the maxillofacial area].
    Ol'shevskiĭ VA
    Stomatologiia (Mosk); 1983; 62(2):43-5. PubMed ID: 6574633
    [No Abstract]   [Full Text] [Related]  

  • 44. [The mechanism of action of autohemotherapy in patients with chronic inflammatory diseases of the maxillofacial region].
    Solov'ev MM; Vasil'ev AV; Alekhova TM
    Stomatologiia (Mosk); 1974; 53(5):86-7. PubMed ID: 4530511
    [No Abstract]   [Full Text] [Related]  

  • 45. [Lipid peroxidation in suppurative-inflammatory diseases of the maxillofacial area].
    Suleĭmanova SG; Seidbekova OS; Alekperova NV
    Stomatologiia (Mosk); 1992; (1):36-7. PubMed ID: 1440672
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Differences in the immune status of patients with chronic odontogenic inflammatory processes of the maxillofacial area].
    Robustova TG; Kostishin ID
    Stomatologiia (Mosk); 1986; 65(4):31-3. PubMed ID: 3462977
    [No Abstract]   [Full Text] [Related]  

  • 47. [A comparative evaluation of various methods for determining the degree of endogenous intoxication in patients with phlegmons of the maxillofacial area].
    Ganina SS; Perbokas F; Gabriélian NI; Belotserkovskaia OI
    Stomatologiia (Mosk); 1990; 69(2):32-4. PubMed ID: 2371725
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Immunological aspects of the effect of inflammatory diseases of the maxillofacial area on the brain].
    Chuĭkin SV
    Stomatologiia (Mosk); 1989; 68(3):32-5. PubMed ID: 2772934
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Relationship of the indices of the T-, B- and A-immune systems of patients with phlegmons of the maxillofacial area].
    Robustova TG; Lebedev KA; Ushakov RV; Poniakina ID
    Stomatologiia (Mosk); 1985; 64(4):35-7. PubMed ID: 3876620
    [No Abstract]   [Full Text] [Related]  

  • 50. [The use of the preparation baliz-2 in inflammatory processes of the maxillofacial area].
    Bernadskaia GP; Timofeev AA; Kutsenko TA
    Stomatologiia (Mosk); 1989; 68(6):10-1. PubMed ID: 2623675
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [The clinico-experimental validation of carbon sorption drainage in treating suppurative-inflammatory diseases of the maxillofacial area in children].
    Supiev TK; Kotova AL; Nurmaganov SB; Galiapin AS; Baĭshulakov AA
    Stomatologiia (Mosk); 1991; (2):71-4. PubMed ID: 1853392
    [No Abstract]   [Full Text] [Related]  

  • 52. [Focal infection in tooth-mouth- and jaw area and its diagnosis].
    Rost A
    Zahnarztl Prax; 1976 Jun; 27(11):262-6. PubMed ID: 1076946
    [No Abstract]   [Full Text] [Related]  

  • 53. [The use of immunoenzyme analysis for the diagnosis of an anaerobic infection of the maxillofacial area].
    Tsarev VN; Iastrebova NE; Vaneeva NP; Kalinin AI
    Stomatologiia (Mosk); 1995; 74(1):38-40. PubMed ID: 7770877
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [New antimicrobial preparations in the overall treatment of suppurative inflammatory processes in the maxillofacial area].
    Solomennyĭ SM; Paliĭ GK; Burdeniuk IP
    Stomatologiia (Mosk); 1979; 58(2):39-41. PubMed ID: 375477
    [No Abstract]   [Full Text] [Related]  

  • 55. [The therapy of inflammatory diseases of the maxillofacial area with the use of imidazole derivatives].
    Ushakov RV; Tsarev VN; Dugarov BD; Lopyrev VA
    Stomatologiia (Mosk); 1992; (3-6):31-4. PubMed ID: 1307150
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Use of hyperbaric oxygenation in the combined treatment of acute inflammatory processes of the soft tissues of the maxillofacial area].
    Kurakin AV; Karapetian IS; Volozhin AI; Sidel'nikova GM; Pomerantseva EN
    Stomatologiia (Mosk); 1982; 61(5):36-8. PubMed ID: 6959389
    [No Abstract]   [Full Text] [Related]  

  • 57. [Clinical and experimental bases for using dibasol in inflammatory diseases of the maxillofacial area].
    Alekhova TM
    Stomatologiia (Mosk); 1982; 61(1):15-7. PubMed ID: 6950550
    [No Abstract]   [Full Text] [Related]  

  • 58. [Blood immunoglobulin content and concentration ratios in inflammatory processes of the maxillofacial area].
    Zavada IG; Makhlin NV; Zuev VP
    Stomatologiia (Mosk); 1984; 63(2):29-31. PubMed ID: 6587624
    [No Abstract]   [Full Text] [Related]  

  • 59. [Acute odontogenic osteomyelitis of the jaw bones in children in the North].
    Evstifeev ED; Zenovskiĭ VP
    Stomatologiia (Mosk); 1986; 65(6):45-6. PubMed ID: 2948300
    [No Abstract]   [Full Text] [Related]  

  • 60. [The use of netromycin in suppurative maxillofacial surgery in children].
    Roginskiĭ VV; Gerchikov LN; Raĭlian SK; Beliaeva EI; Pavelko GA
    Stomatologiia (Mosk); 1994; 73(3):68-71. PubMed ID: 7846723
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.